Nexvet Biopharma, a veterinary biologics developer, has signed a manufacturing agreement with FUJIFILM Diosynth Biotechnologies (Fujifilm) to provide future clinical-scale biomanufacturing services for Nexvet’s product candidates, NV-01 and NV-02, being developed for chronic pain management in dogs and cats. Under the contract, Fujifilm may also become the commercial manufacturer of these products.   “We look forward to working with Fujifilm on the manufacturing processes for our v...